Despite these totals, the long-term trend in cancer mortality reflects significant progress. As of 2023, the age-adjusted cancer death rate had dropped by 34% from its peak in 1991, averting an ...
Jakel shared the story of a young mother who had been deemed difficult and “in denial” by other staff due to her rejecting ...
Deborah (Debi) A. Boyle MSN, RN, AOCNS, FAAN, is editor in chief of Oncology Nursing News®. She is a long tenured oncology clinical nurse specialist who has practiced in both Comprehensive Cancer ...
The FDA has accepted and granted priority review to a supplemental biologics license for datopotamab deruxtecan-dlnk ...
The advantage of MCED testing is its potential to identify cancers at earlier, more treatable stages; detecting cancer even ...
An advocate is not the same as a health care proxy who is assigned to speak for a patient on their advanced directives.
She noted that she became a better nurse under his mentorship, thanks to the “wisdom and skills he instilled in [her].” His ...
The FDA approved a larger vial size of nelarabine for the treatment of pediatric and adult patients with T-ALL and T-LBL. The FDA approved a larger vial size of 375 mg/75 mL for nelarabine (Arranon) ...
Recent clinical developments in the treatment of platinum-resistant ovarian cancer (PROC) have introduced several novel therapeutic classes, including selective glucocorticoid receptor antagonists, ...
The combination of subcutaneous daratumumab with VRd was approved in July 2024 for induction and consolidation in patients ...
A patient acuity model drove efficient and safe staffing through data from a natural language processing model informed by oncology nurse insights. Predicting proper nurse staffing levels in infusion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results